{
  "retracted": false,
  "timestamp": 1536883200000,
  "updates": [
    {
      "timestamp": 1585016280703,
      "identifier": {
        "doi": "10.1038/s41375-018-0235-5"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1038/leu.2017.173"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction: Pomalidomide, bortezomib, and low-dose dexamethasone in lenalidomide-refractory and proteasome inhibitor-exposed myeloma"
}
